Postpartum Depression Blood Biomarkers

*Data from 37 pregnant women from bloods taken at 24-weeks gestation comparing between screened as high-risk for postpartum depression (PPD) (EPDS >13) and low-risk for PPD (EPDS <13) (Ketim’s proprietary data, all rights reserved).

**EPDS: Edinburgh Postnatal Depression Scale

Provisional patents are in process for both assets.

Discovery

Validation

Qualification

Repeat

A Mental Illness Repository

At Ketim Therapeutics, our Biomarker Database is the foundation for revolutionizing mental health diagnostics and therapeutics. Our approach follows a structured, iterative process:

🔍 Discovery – We leverage high-throughput proteomics, AI-driven analytics, and patient-derived biological samples to identify novel biomarkers linked to postpartum depression (PPD) and other psychiatric disorders.

🧪 Validation – Using independent birth cohorts and rigorous statistical models, we validate these biomarkers, ensuring reproducibility and clinical relevance.

📊 Qualification – We assess biomarker performance in real-world clinical settings, integrating predictive models to refine diagnostic and treatment response tools.

♻️ Repeat – With each addition of a new cohort from around the world, our database grows, enhancing predictive accuracy and expanding our applications beyond PPD into broader neuropsychiatric and neurodegenerative conditions.

This continuous cycle of refinement positions Ketim Therapeutics at the forefront of precision psychiatry—pioneering biomarker-driven solutions that will redefine mental health care.

We are focused on bringing precision medicine to mental health care.

Ketim Therapeutics uses an innovative approach combines various omics technologies with advanced computational methods to significantly enhance the predictive power of these biomarkers.

By integrating diverse biological data and leveraging sophisticated algorithms, Ketim Therapeutics aims to identify reliable and robust biomarkers that can be used for early detection, diagnosis, and personalized treatment of perinatal mental disorders.